Fact CheckerSign in

NCT06225609Not yet recruiting

No Stoma VS Ghost Stoma in Patients Undergoing Total Mesorectal Excision for Rectal Cancer

Ghost Ileostomy Group Versus no Stoma Group in Patients Undergoing Total Mesorectal Excision for Rectal Cancer: A Randomized Controlled Study

Source: ClinicalTrials.gov · Last updated 26 Jan 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study aimed at comparing the Comprehensive Complication Index (CCI), readmission rates, postoperative hospitalization days, duration of bearing the stoma (months), hospitalization costs, the number of hospitalizations with ghost ileostomy group versus no ileostomy group after total mesorectal excision for rectal cancer.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
500 (estimated)
First submitted
17 Jan 2024
Start date
1 Mar 2024
Primary completion date
1 Mar 2025
Lead sponsor
fan li
NCT number
NCT06225609

What you commit to

  • Study type: Interventional
  • Planned participants: 500
  • From 1 Mar 2024 to the primary completion date, 1 Mar 2025
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with a history of myocardial infarction or coronary artery surgery within 6 months before the procedure.

Other illness

  • History of long-term use of immunosuppressive drugs or glucocorticoids.
  • Combined severe cardiac disease: with congestive heart failure or NYHA cardiac function ≥ grade 2.
  • chronic renal failure (requiring dialysis or glomerular filtration rate \<30 mL/min).
    • Intraoperative combined multi-organ resection.

Other

  • ASA score \>3.
  • Patients with coexisting complete intestinal obstruction.
  • Combined cirrhosis of the liver.
  • Intraoperative findings of incomplete anastomosis and positive insufflation test.

Who the study is looking for

  • Pathologically confirmed rectal cancer.
  • age ≥18 years and ≤80 years.
  • intraoperative ghost ileostomy or no stoma was performed.

Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.